Carmen Garrido-Fleury

Title: Carmen Garrido-Fleury: Innovator in Pharmaceutical Treatments

Introduction

Carmen Garrido-Fleury is a notable inventor based in Dijon, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases mediated by specific signaling pathways. With a total of three patents to her name, her work is recognized for its potential impact on various health conditions.

Latest Patents

Carmen's latest patents include innovative methods and pharmaceutical compositions aimed at treating diseases associated with the NRP-1/OBR complex signaling pathway. One of her key inventions focuses on a method for treating conditions such as cancers, obesity, and autoimmune diseases by administering an antagonist of the NRP-1/OBR signaling pathway. Another significant patent involves polypeptides that inhibit the binding between leptin and Neuropilin-1 (NRP1), showcasing her commitment to advancing therapeutic options in the medical field.

Career Highlights

Throughout her career, Carmen has worked with esteemed organizations such as the National Institute of Health and Medical Research (Institut National De La Sante Et De La Recherche Medicale) and the Imagine Foundation. Her work in these institutions has allowed her to develop and refine her innovative ideas, contributing to the advancement of medical research and treatment methodologies.

Collaborations

Carmen has collaborated with notable colleagues, including Renaud Seigneuric and Zakia Belaid-Choucair. These partnerships have fostered a collaborative environment that enhances the development of her groundbreaking inventions.

Conclusion

Carmen Garrido-Fleury stands out as an influential inventor in the pharmaceutical industry. Her innovative patents and collaborative efforts reflect her dedication to improving health outcomes through scientific advancements.